
Among nearly 48 million US adults eligible for obesity medications, oral semaglutide initiation climbed quickly after its December 2025 FDA approval.
The American Journal of Managed Care
over 29 years ago
Hospitals and Managed Care: Catching Up with the Networksover 29 years ago
A Case of Congestive Heart Failure -- The Managed Care Perspective




